EGFR mutation testing in pulmonary adenocarcinoma: Evaluation of tumor cell number and tumor percent in paraffin sections of 120 small biopsies

Lung Cancer

Volumn 87, Issue 1, 2015, Pages 8-13

  Scarpino, Stefania ^a   Pulcini, Federica ^a   Di Napoli, Arianna ^a   Giubettini, Maria ^a   Ruco, Luigi ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bronchial biopsy; EGFR mutations; Lung tumors; Needle biopsy; Tumor cell numbers

Indexed keywords

EOSIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HEMATOXYLIN; PARAFFIN;

AGED; ARTICLE; BRONCHUS BIOPSY; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LUNG ADENOCARCINOMA; MALE; MUTATIONAL ANALYSIS; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; SENSITIVITY ANALYSIS; TRANSTHORACIC BIOPSY; TUMOR BIOPSY; TUMOR CELL; TUMOR VOLUME; ADENOCARCINOMA; BIOPSY; GENE DOSAGE; GENETIC SCREENING; GENETICS; LUNG NEOPLASMS; MUTATION; NUCLEOTIDE SEQUENCE; PROCEDURES;

ADENOCARCINOMA; BIOPSY; DNA MUTATIONAL ANALYSIS; FEMALE; GENE DOSAGE; GENETIC TESTING; HUMANS; LUNG NEOPLASMS; MALE; MUTATION; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR BURDEN;

EID: 84922332315     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.10.012     Document Type: Article

References (20)

1. Lynch T.J., Bell D.W., Sordella R., Gurubhagavatula S., Okimoto R.A., Brannigan B.W., et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004, 350:2129-2139.
2. Paez J.G., Jänne P.A., Lee J.C., Tracy S., Greulich H., Gabriel S., et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004, 304:1497-1500.
3. Pao W., Miller V., Zakowski M., Doherty J., Politi K., Sarkaria I., et al. EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A 2004, 101:13306-13311.
4. Sharma S.V., Bell D.W., Settleman J., Haber D.A. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 2007, 7:169-181.
5. Warth A., Penzel R., Brandt R., Sers C., Fischer J.R., Thomas M., et al. Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies. Virchows Arch 2012, 460:407-414.
6. Pirker R., Herth F.J., Kerr K.M., Filipits M., Taron M., Gandara D., et al. Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol 2010, 5:1706-1713.
7. BeauFaller M., Degeorges A., Rolland E., Mounawar M., Antoine M., Poulot V., et al. Cross-validation study for epidermal growth factor receptor and KRAS mutation detection in 74 blinded non-small cell lung carcinoma samples: a total of 5550 exons sequenced by 15 molecular French laboratories (evaluation of the EGFR mutation status for the administration of EGFR-TKIs in non-small cell lung carcinoma [ERMETIC] project-part 1). J Thorac Oncol 2011, 6:1006-1015.
8. Keedy V.L., Temin S., Somerfield M.R., Beasley M.B., Johnson D.H., McShane L.M., et al. American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy. J Clin Oncol 2011, 29:2121-2127.
9. Ellison G., Zhu G., Moulis A., Dearden S., Speake G., McCormack R. EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples. J Clin Pathol 2013, 66:79-89.
10. Garrido P., de Castro J., Concha Á., Felip E., Isla D., López-Ríos F., et al. Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP). Clin Transl Oncol 2012, 14:338-349.
11. Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011, 6:244-285.
12. Sholl L.M., Iafrate A.J., Chou Y.P., Wu M.T., Goan Y.G., Su L., et al. Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma. Mod Pathol 2007, 20:1028-1035.
13. Penzel R., Sers C., Chen Y., Lehmann-Mühlenhoff U., Merkelbach-Bruse S., Jung A., et al. EGFR mutation detection in NSCLC-assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC. Virchows Arch 2011, 458:95-98.
14. Marchetti A., Martella C., Felicioni L., Barassi F., Salvatore S., Chella A., et al. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol 2005, 23:857-865.
15. Rosell R., Moran T., Queralt C., Porta R., Cardenal F., Camps C., et al. Spanish Lung Cancer Group Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 2009, 361:958-967.
16. Yatabe Y. EGFR mutations and the terminal respiratory unit. Cancer Metastasis Rev 2010, 29:23-36.
17. Soh J., Okumura N., Lockwood W.W., Yamamoto H., Shigematsu H., Zhang W., et al. Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells. PLoS ONE 2009, 4:e7464.
18. Sholl L.M., Yeap B.Y., Iafrate A.J., Holmes-Tisch A.J., Chou Y.P., Wu M.T., et al. Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers. Cancer Res 2009, 69:8341-8348.
19. Yatabe Y., Takahashi T., Mitsudomi T. Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer. Cancer Res 2008, 68:2106-2111.
20. Soh J., Toyooka S., Ichihara S., Asano H., Kobayashi N., Suehisa H., et al. Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung. J Thorac Oncol 2008, 3:340-347.